Please join us in celebrating deborahcollyar of Patient Advocates in Research (PAIR) for receiving the Tara Withington Public Service Award. Thank you for creating a space where research meets reality. LEARN MORE: sitcancer.org/aboutsitc/awar…

GRASP Huddles were developed to answer the demand for more interactions between patients and researchers. Join us this Thursday as Dr. Marielle Gross discusses Decentralized Biobanking (aka "de-bi"). Register today! #huddle #graspcancer #grasphuddles #engage #beyondcancer

I’m honored to bring my friend and respected colleague, Dr. Monica M. Bertagnolli Dr. Monica Bertagnolli to Facts & Faith Fridays for a meaningful conversation. You know I only bring my folk to the table with something great to say right? Join us on Sept 20, 3 pm us02web.zoom.us/webinar/regist…

🌟 Addressing Racial Disparities in Clinical Trials 🌟 We're committed to tackling the barriers that have historically limited racial and ethnic diversity in clinical trial participation. These challenges—ranging from distrust and poor communication to racial bias—require

"Never-words are conversation stoppers". This is an excellent article, probing the use of language and its impact on patients, families & caregivers.

“Many patients are very open to participating in clinical trials once they are asked – they just don’t know a clinical trial could be an option for them,” said UNC Lineberger’s Carrie Lee, MD, MPH. “We, as cancer care providers and researchers, need to do a better job approaching

This is one of my favorite papers to assign for incoming graduate students. And, re-reading it for this morning's class gave me some reminders I needed myself. ✨ journals.biologists.com/jcs/article/12…

Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate - goo.gl/alerts/9wgwzn #GoogleAlerts @MyelomaTeacher - Cindy Chmielewski Todd Kennedy Surviving Myeloma Yelak Biru Teresa Miceli. ❤️&☮️4🌎 Robin Tuohy Vincent Rajkumar Luciano J Costa Beth Faiman PhD Plasma Cell Pete Philip McCarthy

Fantastic IASLC #STARS Scholars get-together! We ate, drank, laughed, and cried, remembering friends we have lost. We all anxiously await the amazing research to be presented at #WCLC24 - a lot of science on innovative treatments & talk about cures, BUT not as much about HELPING

DESTINYBreast 12 presented by Nancy Lin, MD at #ESMO2024 illustrating clear intracranial activity in HER2+ breast cancer with brain Mets - 72% CNS RR! Simultaneously published Nat. Med.

"This review explores the myriad of changes in the current oncology landscape with a focus on the patient perspective & patient-centered care." Proud of this new 📑 from a multidisciplinary team (#radonc #medphys #nursing #socialwork #patientAdvocates) ➡️authors.elsevier.com/a/1jlSR3lXQoYD…

So many outstanding initiatives coming out of UNC Lineberger’s COE dept and their team of rock stars ✨ Novel methods of data collection & analysis, patient advocacy, addressing barriers to #cancercare, and so much more.

Bill Wood Daniel Reuland CCSI An incredible day with many discussions on cutting-edge cancer research, shared breakthroughs, and fostered collaboration. Huge thanks to all speakers and participants for an inspiring event! Also, a warm welcome to our new executive director, Robert Ferris, MD, PhD.

Destiny-Breast12: One of the highlights at #ESMO24 presented by Nancy Lin, MD. Practice changing data for #mBC patients with HER+ disease and brain metastases. So finally patients with active brain metastases are being included in trials. OncoAlert

Incredible science and collaborative accomplishments UNC Lineberger scientific retreat. With special honor for icon Dr Shelley Earp. I am honored to lead UNC health system oncology services and the amazing Lineberger cancer center starting Oct 1.

ABIGAIL (in HR+/HER2-) and the second IA of the DETECT-5 trial (in HR+/HER2+) both found no usefulness of induction chemo prior to starting an ET-based approach, calling into question a common practice. #ESMO2024 OncoAlert

Happy National Postdoc Appreciation Week! I want to personally thank our National Cancer Institute postdocs and trainees for their dedication and innovation. Your work is pushing the boundaries of #CancerResearch and helping to shape a brighter future. I’m proud to work alongside you! #NPAW2024

A recording of Dr. Ethan Basch's #ASCOQLTY24 Joseph Simone Quality Care Award lecture is now available in which he reflects on the evolution of quality improvement in #CancerCare. On the Brink of a Golden Age in Quality Cancer Care: brnw.ch/21wNgPE Ethan Basch

Important article in Journal of Clinical Oncology on Patient Enrollment to Industry v Federally-funded Cancer Clinical Trials: - 26,080trials, 2008-2022 - enrolled pts 8.1fold greater for industry v academic - less focus on q's such as tx duration, de-escalation OncoAlert ascopubs.org/doi/full/10.12…

Perfect timing for our editorial to be published after #ESMO24. 🔝Immunogram of HR+ BC may help to identify patients benefying from ICI. ➡️ find more on our perspective at: esmoopen.com/article/S2059-…